Building Medical Affairs Teams of The Future: A Strategic Advantage in the Age of Data Driven Health

October 14, 2020 8:00 AM - 9:00 AM

Webinar, click "live-stream" button to view

Add to Calendar 10/14/2020 8:00:16 AM 10/14/2020 9:00:16 AM Building Medical Affairs Teams of The Future: A Strategic Advantage in the Age of Data Driven Health

Medical Affairs was created as a support function to marketing and sales but has evolved over the last decade into the third pillar of pharmaceutical and biotechnology companies. Today, with the breadth and depth of diverse data sources, rapid changes in technology, increasing scientific complexity of treatments, and regulatory and economic trends, organizations that cultivate strategic and diversely talented medical teams have the competitive advantage.

Forward looking organizations are building the medical affairs teams of the future. These teams are breaking down traditional silos and developing capacities to evolve data generation across clinical development, HEOR and real-world evidence. They are evolving to effectively translate, not only the clinical, but also the economic impact to increasingly important stakeholders, especially payer decision-makers with unprecedented size and scale and knowledge-empowered patients.

In a day of rapid scientific and medical advancement, equity, and economic concerns, the pharmaceutical industry requires strategic medical leadership. Required are highly skilled and empowered medical affairs teams that harness data and insights to help physicians, payers, and patients choose the right medication, at the right time, to drive meaningful impact for individual patients and societal health outcomes.

Join us for an overview from McKinsey of how medical affairs has evolved over time and where it is headed followed by a panel discussion on how life sciences companies of all sizes can best hire, develop, and leverage these skilled professionals for a competitive advantage.

Sponsored by the MassBio MarCom and Commercial Forum Working Group.

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
 

Webinar, click "live-stream" button to view

Medical Affairs was created as a support function to marketing and sales but has evolved over the last decade into the third pillar of pharmaceutical and biotechnology companies. Today, with the breadth and depth of diverse data sources, rapid changes in technology, increasing scientific complexity of treatments, and regulatory and economic trends, organizations that cultivate strategic and diversely talented medical teams have the competitive advantage.

Forward looking organizations are building the medical affairs teams of the future. These teams are breaking down traditional silos and developing capacities to evolve data generation across clinical development, HEOR and real-world evidence. They are evolving to effectively translate, not only the clinical, but also the economic impact to increasingly important stakeholders, especially payer decision-makers with unprecedented size and scale and knowledge-empowered patients.

In a day of rapid scientific and medical advancement, equity, and economic concerns, the pharmaceutical industry requires strategic medical leadership. Required are highly skilled and empowered medical affairs teams that harness data and insights to help physicians, payers, and patients choose the right medication, at the right time, to drive meaningful impact for individual patients and societal health outcomes.

Join us for an overview from McKinsey of how medical affairs has evolved over time and where it is headed followed by a panel discussion on how life sciences companies of all sizes can best hire, develop, and leverage these skilled professionals for a competitive advantage.

Sponsored by the MassBio MarCom and Commercial Forum Working Group.

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
 

Leader, Preclinical & Clinical Research and Medical Affairs, DePuy Synthes Spine
John Pracyk, MD, PhD, MBA, is an Integrated Leader - Preclinical & Clinical Research and Medical Affairs at DePuy Synthes Spine, (Johnson & Johnson Medical Devices Companies), and President of the Americas, and member of the Board of Directors, The Medical Affairs Professional Society. John is an executive medical affairs leader focusing on the design, development, and commercialization of medical devices. As a Neurological Surgeon/ Neuroscientist with an uncommon blend of business and medical expertise he is a passionate proponent of value-based care and outcomes-driven, evidence-based practices. He is a recognized thought leader and program architect in the creation and management of collaborative healthcare delivery platforms with a proven track record of multidisciplinary program build-outs and care redesign successes. John obtained his BS, MD, and PhD degrees through the Early Identification & Medical Scientist Training Programs at Duke University and was competitively awarded postdoctoral fellowships at The University of Cambridge and The National Institutes of Health. John also obtained a MBA at the Haslam College of Business, at the University of Tennessee, and is a Diplomate of the American Board of Neurological Surgeons, a Fellow of the American Association of Neurological Surgeons (FAANS) and a Fellow of the American College of Surgeons (FACS).